Jazz Pharmaceuticals (JAZZ) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 702.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 702.15% |
| Dec 31, 2025 | 33.43% |
| Sep 30, 2025 | -77.90% |
| Jun 30, 2025 | -444.15% |
| Mar 31, 2025 | -184.43% |
| Dec 31, 2024 | 55.73% |
| Sep 30, 2024 | 50.94% |
| Jun 30, 2024 | 26.52% |
| Mar 31, 2024 | -47.48% |
| Dec 31, 2023 | 146.51% |
| Sep 30, 2023 | 596.17% |
| Jun 30, 2023 | 84.27% |
| Mar 31, 2023 | 43.98% |
| Dec 31, 2022 | -633.39% |
| Sep 30, 2022 | -12.71% |
| Jun 30, 2022 | 222.93% |
| Mar 31, 2022 | -46.00% |
| Dec 31, 2021 | -71.52% |
| Sep 30, 2021 | -85.54% |
| Jun 30, 2021 | -135.12% |
| Mar 31, 2021 | 185.47% |
| Dec 31, 2020 | 183.15% |
| Sep 30, 2020 | 47.41% |
| Jun 30, 2020 | -3.01% |
| Mar 31, 2020 | -241.82% |
| Dec 31, 2019 | -66.90% |
| Sep 30, 2019 | -29.49% |
| Jun 30, 2019 | 33.34% |
| Mar 31, 2019 | 52.31% |
| Dec 31, 2018 | 31.05% |
| Sep 30, 2018 | 118.36% |
| Jun 30, 2018 | -7.18% |
| Mar 31, 2018 | -35.50% |
| Dec 31, 2017 | -14.68% |
| Sep 30, 2017 | -36.55% |
| Jun 30, 2017 | -2.19% |
| Mar 31, 2017 | 12.36% |
| Dec 31, 2016 | 55.22% |
| Sep 30, 2016 | 3.59% |
| Jun 30, 2016 | 10.07% |
| Mar 31, 2016 | 3.77% |
| Dec 31, 2015 | -17.93% |
| Sep 30, 2015 | 126.64% |
| Jun 30, 2015 | 106.35% |
| Mar 31, 2015 | 275.16% |
| Sep 30, 2014 | -42.29% |
| Jun 30, 2014 | -3.60% |
| Mar 31, 2014 | -197.76% |
| Sep 30, 2013 | 81.84% |
| Jun 30, 2013 | 95.47% |
| Mar 31, 2013 | 90.79% |
| Dec 31, 2012 | 78.89% |
| Sep 30, 2012 | 64.08% |
| Jun 30, 2012 | 16.44% |
| Mar 31, 2012 | 58.11% |
| Dec 31, 2011 | 47.50% |
| Sep 30, 2011 | 133.36% |
| Jun 30, 2011 | 219.97% |